In the 4T1 murine model, HCQ monotherapy at 50 mg/kg significantly reduced tumor burden; notably, a lower dose of 10 mg/kg HCQ, when combined with 5 mg/kg DOX, achieved a comparable reduction in tumor growth and c-myc expression. Here, MYC is linked to neoplasm.